(HAL) HAL Trust - Ratings and Ratios
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: BMG455841020
Maritime Services, Orthopedic Devices, Financial Services, Real Estate, Liquid Portfolio
Description: HAL HAL Trust October 31, 2025
HAL Trust (AS:HAL) is a Rotterdam-based conglomerate operating across Europe, North America, and Asia through four segments-Unquoted, Quoted Interests, Real Estate, and Liquid Portfolio. Its portfolio spans maritime services (including emergency response and salvage), construction and infrastructure (composite panels, residential and utility projects, offshore floating facilities), medical and optical products, financial services, and media assets such as BNR Nieuwsradio and Het Financieele Dagblad. Founded in 1873, the group leverages a diversified business model that combines traditional industrial activities with high-growth services like GHG-reduction projects and mortgage funding.
Key metrics that analysts watch include HAL’s total revenue of €2.1 bn in FY 2023, a 5 % YoY increase driven primarily by a rebound in shipping volumes and construction orders, and an EBITDA margin of roughly 9 % reflecting the mix of capital-intensive assets and higher-margin financial services. The company’s exposure to the global shipping cycle (linked to freight rates and vessel utilization) and to European construction demand (sensitive to interest-rate trends and fiscal stimulus) are the dominant economic drivers of its earnings outlook.
For a deeper, data-driven assessment of HAL Trust’s valuation and risk profile, you may find the analytical tools on ValueRay worth exploring.
HAL Stock Overview
| Market Cap in USD | 14,389m |
| Sub-Industry | Asset Management & Custody Banks |
| IPO / Inception |
HAL Stock Ratings
| Growth Rating | 38.7% |
| Fundamental | 74.2% |
| Dividend Rating | 47.2% |
| Return 12m vs S&P 500 | 6.46% |
| Analyst Rating | - |
HAL Dividends
| Dividend Yield 12m | 2.14% |
| Yield on Cost 5y | 2.83% |
| Annual Growth 5y | 0.99% |
| Payout Consistency | 92.9% |
| Payout Ratio | 15.2% |
HAL Growth Ratios
| Growth Correlation 3m | 31.7% |
| Growth Correlation 12m | 88.5% |
| Growth Correlation 5y | -20.8% |
| CAGR 5y | 4.41% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.24 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.60 |
| Sharpe Ratio 12m | -0.26 |
| Alpha | 9.56 |
| Beta | 0.657 |
| Volatility | 12.30% |
| Current Volume | 10.5k |
| Average Volume 20d | 10.2k |
| Stop Loss | 131.7 (-3%) |
| Signal | 0.12 |
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income (1.50b TTM) > 0 and > 6% of Revenue (6% = 1.15b TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 3.95pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 14.12% (prev 21.65%; Δ -7.53pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 3.62b > Net Income 1.50b (YES >=105%, WARN >=100%) |
| Net Debt (1.17b) to EBITDA (3.92b) ratio: 0.30 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.48 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (90.4m) change vs 12m ago -0.01% (target <= -2.0% for YES) |
| Gross Margin 34.54% (prev 23.37%; Δ 11.17pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 71.16% (prev 50.94%; Δ 20.22pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.54 (EBITDA TTM 3.92b / Interest Expense TTM 324.4m) >= 6 (WARN >= 3) |
Altman Z'' 1.89
| (A) 0.10 = (Total Current Assets 8.34b - Total Current Liabilities 5.64b) / Total Assets 27.48b |
| (B) 0.11 = Retained Earnings (Balance) 2.89b / Total Assets 27.48b |
| (C) 0.09 = EBIT TTM 2.45b / Avg Total Assets 26.91b |
| (D) 0.28 = Book Value of Equity 2.89b / Total Liabilities 10.43b |
| Total Rating: 1.89 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 74.20
| 1. Piotroski 9.0pt = 4.0 |
| 2. FCF Yield 13.38% = 5.0 |
| 3. FCF Margin 9.55% = 2.39 |
| 4. Debt/Equity 0.24 = 2.47 |
| 5. Debt/Ebitda 0.30 = 2.43 |
| 6. ROIC - WACC (= 3.61)% = 4.51 |
| 7. RoE 10.43% = 0.87 |
| 8. Rev. Trend 33.69% = 2.53 |
| 10. EPS Trend data missing |
What is the price of HAL shares?
As of November 09, 2025, the stock is trading at EUR 135.80 with a total of 10,465 shares traded.
Over the past week, the price has changed by -0.29%, over one month by +0.59%, over three months by +8.99% and over the past year by +21.38%.
Over the past week, the price has changed by -0.29%, over one month by +0.59%, over three months by +8.99% and over the past year by +21.38%.
Is HAL Trust a good stock to buy?
Partly, yes. Based on ValueRay´s Fundamental Analyses, HAL Trust (AS:HAL) is currently (November 2025)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 74.20 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HAL is around 129.48 EUR . This means that HAL is currently overvalued and has a potential downside of -4.65%.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HAL is around 129.48 EUR . This means that HAL is currently overvalued and has a potential downside of -4.65%.
Is HAL a buy, sell or hold?
HAL Trust has no consensus analysts rating.
What are the forecasts/targets for the HAL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 161.3 | 18.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 142.9 | 5.2% |
HAL Fundamental Data Overview January 01, 1970
Market Cap USD = 14.39b (12.50b EUR * 1.1507 EUR.USD)
Market Cap EUR = 12.50b (12.50b EUR * 1.0 EUR.EUR)
P/E Trailing = 7.2575
P/S = 0.9224
P/B = 0.8204
Beta = 0.657
Revenue TTM = 19.15b EUR
EBIT TTM = 2.45b EUR
EBITDA TTM = 3.92b EUR
Long Term Debt = 2.82b EUR (from longTermDebt, last quarter)
Short Term Debt = 827.6m EUR (from shortLongTermDebt, last quarter)
Debt = 3.65b EUR (Calculated: Short Term 827.6m + Long Term 2.82b)
Net Debt = 1.17b EUR (from netDebt column, last quarter)
Enterprise Value = 13.67b EUR (12.50b + Debt 3.65b - CCE 2.48b)
Interest Coverage Ratio = 7.54 (Ebit TTM 2.45b / Interest Expense TTM 324.4m)
FCF Yield = 13.38% (FCF TTM 1.83b / Enterprise Value 13.67b)
FCF Margin = 9.55% (FCF TTM 1.83b / Revenue TTM 19.15b)
Net Margin = 7.84% (Net Income TTM 1.50b / Revenue TTM 19.15b)
Gross Margin = 34.54% ((Revenue TTM 19.15b - Cost of Revenue TTM 12.54b) / Revenue TTM)
Gross Margin QoQ = 24.03% (prev 54.67%)
Tobins Q-Ratio = 0.50 (Enterprise Value 13.67b / Total Assets 27.48b)
Interest Expense / Debt = 4.34% (Interest Expense 158.2m / Debt 3.65b)
Taxrate = 18.97% (66.5m / 350.6m)
NOPAT = 1.98b (EBIT 2.45b * (1 - 18.97%))
Current Ratio = 1.48 (Total Current Assets 8.34b / Total Current Liabilities 5.64b)
Debt / Equity = 0.24 (Debt 3.65b / totalStockholderEquity, last quarter 15.06b)
Debt / EBITDA = 0.30 (Net Debt 1.17b / EBITDA 3.92b)
Debt / FCF = 0.64 (Net Debt 1.17b / FCF TTM 1.83b)
Total Stockholder Equity = 14.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.46% (Net Income 1.50b / Total Assets 27.48b)
RoE = 10.43% (Net Income TTM 1.50b / Total Stockholder Equity 14.38b)
RoCE = 14.21% (EBIT 2.45b / Capital Employed (Equity 14.38b + L.T.Debt 2.82b))
RoIC = 10.94% (NOPAT 1.98b / Invested Capital 18.12b)
WACC = 7.33% (E(12.50b)/V(16.15b) * Re(8.44%) + D(3.65b)/V(16.15b) * Rd(4.34%) * (1-Tc(0.19)))
Discount Rate = 8.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 2.08%
[DCF Debug] Terminal Value 80.17% ; FCFE base≈1.38b ; Y1≈1.71b ; Y5≈2.91b
Fair Price DCF = 507.3 (DCF Value 45.84b / Shares Outstanding 90.4m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 33.69 | Revenue CAGR: 37.62% | SUE: -0.29 | # QB: 0
Market Cap EUR = 12.50b (12.50b EUR * 1.0 EUR.EUR)
P/E Trailing = 7.2575
P/S = 0.9224
P/B = 0.8204
Beta = 0.657
Revenue TTM = 19.15b EUR
EBIT TTM = 2.45b EUR
EBITDA TTM = 3.92b EUR
Long Term Debt = 2.82b EUR (from longTermDebt, last quarter)
Short Term Debt = 827.6m EUR (from shortLongTermDebt, last quarter)
Debt = 3.65b EUR (Calculated: Short Term 827.6m + Long Term 2.82b)
Net Debt = 1.17b EUR (from netDebt column, last quarter)
Enterprise Value = 13.67b EUR (12.50b + Debt 3.65b - CCE 2.48b)
Interest Coverage Ratio = 7.54 (Ebit TTM 2.45b / Interest Expense TTM 324.4m)
FCF Yield = 13.38% (FCF TTM 1.83b / Enterprise Value 13.67b)
FCF Margin = 9.55% (FCF TTM 1.83b / Revenue TTM 19.15b)
Net Margin = 7.84% (Net Income TTM 1.50b / Revenue TTM 19.15b)
Gross Margin = 34.54% ((Revenue TTM 19.15b - Cost of Revenue TTM 12.54b) / Revenue TTM)
Gross Margin QoQ = 24.03% (prev 54.67%)
Tobins Q-Ratio = 0.50 (Enterprise Value 13.67b / Total Assets 27.48b)
Interest Expense / Debt = 4.34% (Interest Expense 158.2m / Debt 3.65b)
Taxrate = 18.97% (66.5m / 350.6m)
NOPAT = 1.98b (EBIT 2.45b * (1 - 18.97%))
Current Ratio = 1.48 (Total Current Assets 8.34b / Total Current Liabilities 5.64b)
Debt / Equity = 0.24 (Debt 3.65b / totalStockholderEquity, last quarter 15.06b)
Debt / EBITDA = 0.30 (Net Debt 1.17b / EBITDA 3.92b)
Debt / FCF = 0.64 (Net Debt 1.17b / FCF TTM 1.83b)
Total Stockholder Equity = 14.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.46% (Net Income 1.50b / Total Assets 27.48b)
RoE = 10.43% (Net Income TTM 1.50b / Total Stockholder Equity 14.38b)
RoCE = 14.21% (EBIT 2.45b / Capital Employed (Equity 14.38b + L.T.Debt 2.82b))
RoIC = 10.94% (NOPAT 1.98b / Invested Capital 18.12b)
WACC = 7.33% (E(12.50b)/V(16.15b) * Re(8.44%) + D(3.65b)/V(16.15b) * Rd(4.34%) * (1-Tc(0.19)))
Discount Rate = 8.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 2.08%
[DCF Debug] Terminal Value 80.17% ; FCFE base≈1.38b ; Y1≈1.71b ; Y5≈2.91b
Fair Price DCF = 507.3 (DCF Value 45.84b / Shares Outstanding 90.4m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 33.69 | Revenue CAGR: 37.62% | SUE: -0.29 | # QB: 0